PubRank

H Ording

Author PubWeight™ 25.43‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A clinical grading scale to predict malignant hyperthermia susceptibility. Anesthesiology 1994 3.23
2 Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia. Nat Genet 1993 1.45
3 Tactile and visual evaluation of the response to train-of-four nerve stimulation. Anesthesiology 1985 1.14
4 Incidence of malignant hyperthermia in Denmark. Anesth Analg 1985 1.08
5 Osteogenesis imperfecta and malignant hyperthermia. Is there a relationship? Anaesthesia 1996 1.04
6 Posttetanic count (PTC): a new method of evaluating an intense nondepolarizing neuromuscular blockade. Anesthesiology 1981 0.98
7 Identification of novel mutations in the ryanodine-receptor gene (RYR1) in malignant hyperthermia: genotype-phenotype correlation. Am J Hum Genet 1998 0.96
8 Residual curarization in the recovery room. Anesthesiology 1979 0.93
9 Sleep disturbances in critically ill patients in ICU: how much do we know? Acta Anaesthesiol Scand 2012 0.93
10 Detection of a novel mutation at amino acid position 614 in the ryanodine receptor in malignant hyperthermia. Br J Anaesth 1997 0.87
11 Ca(2+)-ATPase and Na(+)-K(+)-ATPase content in skeletal muscle from malignant hyperthermia patients. Muscle Nerve 1992 0.83
12 How do anaesthesiologists treat malignant hyperthermia in a full-scale anaesthesia simulator? Acta Anaesthesiol Scand 2001 0.82
13 Postoperative pain control by epidural analgesia after transabdominal surgery. Efficacy and problems encountered in daily routine. Acta Anaesthesiol Scand 2000 0.81
14 [Testing of neuromuscular function during anaesthesia (author's transl)]. Anesth Analg (Paris) 1980 0.80
15 A multicenter study of 4-chloro-m-cresol for diagnosing malignant hyperthermia susceptibility. Anesth Analg 2000 0.79
16 Efficacy of A-line AEP Monitor as a tool for predicting acceptable tracheal intubation conditions during sevoflurane anaesthesia. Br J Anaesth 2005 0.78
17 Clinical variability of possible malignant hyperthermia as revealed by two cases. Acta Anaesthesiol Belg 1994 0.78
18 Discordance between malignant hyperthermia susceptibility and RYR1 mutation C1840T in two Scandinavian MH families exhibiting this mutation. Clin Genet 1997 0.78
19 A new nerve stimulator (Myotest). Br J Anaesth 1980 0.78
20 Malignant hyperthermia triggered by heating in anaesthetized pigs. Acta Anaesthesiol Scand 1985 0.78
21 Reproducibility of in vitro contracture test results in patients tested for malignant hyperthermia susceptibility. Acta Anaesthesiol Scand 2002 0.78
22 RYR mutation G1021A (Gly341Arg) is not frequent in Danish and Swedish families with malignant hyperthermia susceptibility. Clin Genet 1996 0.77
23 Bispectral index monitoring: comparison of two types of electrode. Anaesthesia 2000 0.77
24 Efficacy of the A-line AEP monitor as a tool for predicting successful insertion of a laryngeal mask during sevoflurane anesthesia. Acta Anaesthesiol Scand 2004 0.77
25 Pretreatment with non-depolarizing muscle relaxants: the influence on neuromuscular transmission and pulmonary function. Acta Anaesthesiol Scand 1980 0.77
26 The Sophus anaesthesia simulator v. 2.0. A Windows 95 control-center of a full-scale simulator. Int J Clin Monit Comput 1997 0.77
27 Atracurium and its antagonism by neostigmine (plus glycopyrrolate) in patients susceptible to malignant hyperthermia. Br J Anaesth 1986 0.77
28 Analysis of anaesthesia in patients suspected to be susceptible to malignant hyperthermia before diagnostic in vitro contracture test. Acta Anaesthesiol Scand 1997 0.76
29 Precurarization with vecuronium and pancuronium in awake, healthy volunteers: the influence on neuromuscular transmission and pulmonary function. Acta Anaesthesiol Scand 1985 0.75
30 In vitro diagnosis of susceptibility to malignant hyperthermia: comparison between dynamic and static halothane and caffeine tests. Acta Anaesthesiol Scand 1987 0.75
31 Dose-response relationships and neuromuscular blocking effects of vecuronium pancuronium during ketamine anaesthesia. Br J Anaesth 1984 0.75
32 Results of in vitro contracture testing of both parents of malignant hyperthermia susceptible probands. Acta Anaesthesiol Scand 1996 0.75
33 [Malignant hyperthermia]. Ugeskr Laeger 1978 0.75
34 [Renal side-effects of intraoperative and postoperative pain treatment with non-steroidal anti-inflammatory drugs]. Ugeskr Laeger 1995 0.75
35 In vitro diagnosis of susceptibility to malignant hyperthermia: evaluation of tests with halothane-caffeine, potassium chloride, suxamethonium and caffeine-suxamethonium. Acta Anaesthesiol Scand 1987 0.75
36 Plasma cholinesterase and malignant hyperthermia. Br J Anaesth 1981 0.75
37 Cardiac effects of vecuronium and pancuronium during halothane anaesthesia. Br J Anaesth 1983 0.75
38 Effects of prenalterol on cardiac performance and transmural myocardial perfusion in patients with chronic renal failure. Eur J Clin Pharmacol 1983 0.75
39 Neuromuscular blocking effects of vecuronium and pancuronium during halothane anaesthesia. Br J Anaesth 1983 0.75
40 [Glycopyrron (Robinul). An anticholinergic agent with new indications]. Ugeskr Laeger 1984 0.75
41 A new infusion design for atracurium and vecuronium. Eur J Anaesthesiol 1987 0.75
42 Influence of salbutamol on the in vitro muscle response to caffeine and halothane in malignant hyperthermia. Acta Anaesthesiol Scand 1990 0.75
43 Search for three known mutations in the RYR1 gene in 48 Danish families with malignant hyperthermia. Clin Genet 1994 0.75
44 [Monitoring of neuromuscular function]. Ugeskr Laeger 1980 0.75
45 Investigation of malignant hyperthermia in Denmark and Sweden. Br J Anaesth 1984 0.75
46 Ketanserin and malignant hyperthermia in pigs. Acta Anaesthesiol Scand 1986 0.75
47 Edrophonium and neostigmine for reversal of the neuromuscular blocking effect of vecuronium. Acta Anaesthesiol Scand 1985 0.75
48 Effect of vecuronium and pancuronium on cardiac performance and transmural myocardial perfusion during ketamine anaesthesia. Acta Anaesthesiol Scand 1984 0.75
49 Dose-response curves for vecuronium during halothane and neurolept anaesthesia: single bolus versus cumulative method. Acta Anaesthesiol Scand 1985 0.75